Puma, but not noxa is essential for oligodendroglial cell death

GLIA

Volumn 61, Issue 10, 2013, Pages 1712-1723

  Hagemeier, Karin ^a   Lürbke, Alexander ^a   Hucke, Stephanie ^a   Albrecht, Stefanie ^a   Preisner, Anna ^a   Klassen, Elena ^a   Hoffmann, Elke ^a   Cui, Qiao Ling ^b   Antel J, Jack ^b   Brück, Wolfgang ^c   Klotz, Luisca ^a   Kuhlmann, Tanja ^a  

^a UNIVERSITY HOSPITAL MÜNSTER   (Germany)

^b MCGILL UNIVERSITY   (Canada)

^c UNIVERSITY MEDICAL CENTER GÖTTINGEN   (Germany)

Author keywords

Apoptosis; BH3 only protein; Cuprizone model; Demyelinating diseases

Indexed keywords

CASPASE 3; GAMMA INTERFERON; INTERLEUKIN 1BETA; NITRIC OXIDE; PROTEIN NOXA; PUMA PROTEIN; STAUROSPORINE; TUMOR NECROSIS FACTOR ALPHA;

ADULT; AGED; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; APOPTOSIS; ARTICLE; CELL DEATH; CLINICAL ARTICLE; CONTROLLED STUDY; DEMYELINATION; ENZYME ACTIVATION; FEMALE; HUMAN; IN VITRO STUDY; IN VIVO STUDY; INFLAMMATION; MALE; MULTIPLE SCLEROSIS; NERVE CELL DIFFERENTIATION; NERVE CELL NECROSIS; NONHUMAN; OLIGODENDROGLIA; PRIORITY JOURNAL; PROTEIN EXPRESSION; UPREGULATION; WEIGHT REDUCTION; WHITE MATTER;

APOPTOSIS; BH3 ONLY PROTEIN; CUPRIZONE MODEL; DEMYELINATING DISEASES;

ADULT; AGED; ANALYSIS OF VARIANCE; ANIMALS; ANIMALS, NEWBORN; APOPTOSIS REGULATORY PROTEINS; BRAIN; CELL DEATH; CELLS, CULTURED; CUPRIZONE; DEMYELINATING DISEASES; DISEASE MODELS, ANIMAL; FEMALE; FLOW CYTOMETRY; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; HUMANS; IN SITU NICK-END LABELING; INTERFERON-GAMMA; LIPOPOLYSACCHARIDES; MALE; MICE; MICE, INBRED C57BL; MICE, TRANSGENIC; MIDDLE AGED; MULTIPLE SCLEROSIS; OLIGODENDROGLIA; PEPTIDE FRAGMENTS; PROTO-ONCOGENE PROTEINS C-BCL-2; TUMOR SUPPRESSOR PROTEINS;

EID: 84882846954     PISSN: 08941491     EISSN: 10981136     Source Type: Journal    
DOI: 10.1002/glia.22552     Document Type: Article

References (54)

1. Adams JM, Cory S. 2007. The Bcl-2 apoptotic switch in cancer development and therapy. Oncogene 26:1324-1337.
2. Akhtar RS, Geng Y, Klocke BJ, Latham CB, Villunger A, Michalak EM, Strasser A, Carroll SL, Roth KA. 2006. BH3-only proapoptotic Bcl-2 family members Noxa and Puma mediate neural precursor cell death. J Neurosci 26:7257-7264.
3. Arnett HA, Mason J, Marino M, Suzuki K, Matsushima GK, Ting JPY. 2001. TNFα promotes proliferation of oligodendrocyte progenitors and remyelination. Nat Neurosci 4:1116-1122.
4. Binder MD, Cate HS, Prieto AL, Kemper D, Butzkueven H, Gresle MM, Cipriani T, Jokubaitis VG, Carmeliet P, Kilpatrick TJ. 2008. Gas6 deficiency increases oligodendrocyte loss and microglial activation in response to cuprizone-induced demyelination. J Neurosci 28:5195-5206.
5. Chen L, Willis SN, Wei A, Smith BJ, Fletcher JI, Hinds MG, Colman PM, Day CL, Adams JM, Huang DC. 2005. Differential targeting of prosurvival Bcl-2 proteins by their BH3-only ligands allows complementary apoptotic function. Mol Cell 17:393-403.
6. Copray JC, Kust BM, Mantingh-Otter I, Boddeke HW. 2005. p75NTR independent oligodendrocyte death in cuprizone-induced demyelination in C57BL/6 mice. Neuropathol Appl Neurobiol 31:600-609.
7. D'Souza SD, Alinauskas KA, Antel JP. 1996a. Ciliary neurotrophic factor selectively protects human oligodendrocytes from tumor necrosis factor-mediated injury. J Neurosci Res 43:289-298.
8. D'Souza SD, Bonetti B, Balasingam V, Cashman NR, Barker PA, Troutt AB, Raine CS, Antel JP. 1996b. Multiple sclerosis: Fas signaling in oligodendrocyte cell death. J Exp Med 184:2361-2370.
9. Galehdar Z, Swan P, Fuerth B, Callaghan SM, Park DS, Cregan SP. 2010. Neuronal apoptosis induced by endoplasmic reticulum stress is regulated by ATF4-CHOP-mediated induction of the Bcl-2 homology 3-only member PUMA. J Neurosci 30:16938-16948.
10. Garrison SP, Jeffers JR, Yang C, Nilsson JA, Hall MA, Rehg JE, Yue W, Yu J, Zhang L, Onciu M, Sample JT, Cleveland JL, Zambetti GP. 2008. Selection against PUMA gene expression in Myc-driven B-cell lymphomagenesis. Mol Cell Biol 28:5391-5402.
11. Ghosh AP, Walls KC, Klocke BJ, Toms R, Strasser A, Roth KA. 2009. The proapoptotic BH3-only, Bcl-2 family member, Puma is critical for acute ethanol-induced neuronal apoptosis. J Neuropathol Exp Neurol 68:747-756.
12. Haider L, Fischer MT, Frischer JM, Bauer J, Hoftberger R, Botond G, Esterbauer H, Binder CJ, Witztum JL, Lassmann H. 2011. Oxidative damage in multiple sclerosis lesions. Brain 134:1914-1924.
13. Hesse A, Wagner M, Held J, Bruck W, Salinas-Riester G, Hao Z, Waisman A, Kuhlmann T. 2010. In toxic demyelination oligodendroglial cell death occurs early and is FAS independent. Neurobiol Dis 37:362-369.
14. Hucke S, Flossdorf J, Grutzke B, Dunay IR, Frenzel K, Jungverdorben J, Linnartz B, Mack M, Peitz M, Brustle O, Kurts C, Klockgether T, Neumann H, Prinz M, Wiendl H, Knolle P, Klotz L. 2012. Licensing of myeloid cells promotes central nervous system autoimmunity and is controlled by peroxisome proliferator-activated receptor gamma. Brain 135:1586-1605.
15. Jack C, Antel J, Bruck W, Kuhlmann T. 2007. Contrasting potential of nitric oxide and peroxynitrite to mediate oligodendrocyte injury in multiple sclerosis. Glia 55:926-934.
16. Kaeser MD, Iggo RD. 2002. Chromatin immunoprecipitation analysis fails to support the latency model for regulation of p53 DNA binding activity in vivo. Proc Natl Acad Sci USA 99:95-100.
17. Karst AM, Dai DL, Cheng JQ, Li G. 2006. Role of p53 up-regulated modulator of apoptosis and phosphorylated Akt in melanoma cell growth, apoptosis, and patient survival. Cancer Res 66:9221-9226.
18. Kieran D, Woods I, Villunger A, Strasser A, Prehn JH. 2007. Deletion of the BH3-only protein puma protects motoneurons from ER stress-induced apoptosis and delays motoneuron loss in ALS mice. Proc Natl Acad Sci USA 104:20606-20611.
19. Kiryu-Seo S, Hirayama T, Kato R, Kiyama H. 2005. Noxa is a critical mediator of p53-dependent motor neuron death after nerve injury in adult mouse. J Neurosci 25:1442-1447.
20. Kuhlmann T, Lucchinetti C, Zettl UK, Bitsch A, Lassmann H, Brück W. 1999. Bcl-2-expressing oligodendrocytes in multiple sclerosis lesions. Glia 28:34-39.
21. Kuwana T, Bouchier-Hayes L, Chipuk JE, Bonzon C, Sullivan BA, Green DR, Newmeyer DD. 2005. BH3 domains of BH3-only proteins differentially regulate Bax-mediated mitochondrial membrane permeabilization both directly and indirectly. Mol Cell 17:525-535.
22. Ladiwala U, Li H, Antel JP, Nalbantoglu J. 1999. p53 induction by tumor necrosis factor-α and involvement of p53 in cell death of human oligodendrocytes. J Neurochem 73:605-611.
23. Li J, Ghiani CA, Kim JY, Liu A, Sandoval J, deVellis J, Casaccia-Bonnefil P. 2008. Inhibition of p53 transcriptional activity: A potential target for future development of therapeutic strategies for primary demyelination. J Neurosci 28:6118-6127.
24. Louis JC, Magal E, Muir D, Manthorpe M, Varon S. 1992. CG-4, a new bipotential glial cell line from rat brain, is capable of differentiating in vitro into either mature oligodendrocytes or type-2 astrocytes. J Neurosci Res 31:193-204.
25. Lucchinetti C, Brück W, Parisi J, Scheithauer B, Rodriguez M, Lassmann H. 1999. A quantitative analysis of oligodendrocytes in multiple sclerosis lesions. A study of 113 cases. Brain 122:2279-2295.
26. Lucchinetti C, Brück W, Parisi J, Scheithauer B, Rodriguez M, Lassmann H. 2000. Heterogeneity of multiple sclerosis lesions: Implications for the pathogenesis of demyelination. Ann Neurol 47:707-717.
27. Mahad D, Ziabreva I, Lassmann H, Turnbull D. 2008. Mitochondrial defects in acute multiple sclerosis lesions. Brain 131:1722-1735.
28. Mason JL, Jones JJ, Taniike M, Morell P, Suzuki K, Matsushima GK. 2000. Mature oligodendrocyte apoptosis precedes IGF-1 production and oligodendrocyte progenitor accumulation and differentiation during demyelination/remyelination. J Neurosci Res 61:251-262.
29. Matsushima GK, Morell P. 2001. The neurotoxicant, cuprizone, as a model to study demyelination and remyelination in the central nervous system. Brain Pathol 11:107-116.
30. McMahon EJ, Cook DN, Suzuki K, Matsushima GK. 2001. Absence of macrophage-inflammatory protein-1alpha delays central nervous system demyelination in the presence of an intact blood-brain barrier. J Immunol 167:2964-2971.
31. Michalak EM, Villunger A, Adams JM, Strasser A. 2008. In several cell types tumour suppressor p53 induces apoptosis largely via Puma but Noxa can contribute. Cell Death Differ 15:1019-1029.
32. Mosmann T. 1983. Rapid colorimetric assay for cellular growth and survival: Application to proliferation and cytotoxicity assays. J Immunol Methods 65:55-63.
33. Mustata G, Li M, Zevola N, Bakan A, Zhang L, Epperly M, Greenberger JS, Yu J, Bahar I. 2011. Development of small-molecule PUMA inhibitors for mitigating radiation-induced cell death. Curr Top Med Chem 11:281-290.
34. Oda E, Ohki R, Murasawa H, Nemoto J, Shibue T, Yamashita T, Tokino T, Taniguchi T, Tanaka N. 2000. Noxa, a BH3-only member of the Bcl-2 family and candidate mediator of p53-induced apoptosis. Science 288:1053-1058.
35. Pasquini LA, Calatayud CA, Bertone Una AL, Millet V, Pasquini JM, Soto EF. 2007. The neurotoxic effect of cuprizone on oligodendrocytes depends on the presence of pro-inflammatory cytokines secreted by microglia. Neurochem Res 32:279-292.
36. Plant SR, Arnett HA, Ting JP. 2005. Astroglial-derived lymphotoxin-alpha exacerbates inflammation and demyelination, but not remyelination. Glia 49:1-14.
37. Ploner C, Kofler R, Villunger A. 2008. Noxa: At the tip of the balance between life and death. Oncogene 27:S84-S92.
38. Reimertz C, Kogel D, Rami A, Chittenden T, Prehn JH. 2003. Gene expression during ER stress-induced apoptosis in neurons: Induction of the BH3-only protein Bbc3/PUMA and activation of the mitochondrial apoptosis pathway. J Cell Biol 162:587-597.
39. Ren D, Tu HC, Kim H, Wang GX, Bean GR, Takeuchi O, Jeffers JR, Zambetti GP, Hsieh JJ, Cheng EH. 2010. BID, BIM, and PUMA are essential for activation of the BAX- and BAK-dependent cell death program. Science 330:1390-1393.
40. Richter-Landsberg C, Heinrich M. 1996. OLN-93: A new permanent oligodendroglia cell line derived from primary rat brain glial cultures. J Neurosci Res 45:161-173.
41. Rodriguez-Aznar E, Nieto MA. 2011. Repression of Puma by scratch2 is required for neuronal survival during embryonic development. Cell Death Differ 18:1196-1207.
42. Steckley D, Karajgikar M, Dale LB, Fuerth B, Swan P, Drummond-Main C, Poulter MO, Ferguson SS, Strasser A, Cregan SP. 2007. Puma is a dominant regulator of oxidative stress induced Bax activation and neuronal apoptosis. J Neurosci 27:12989-12999.
43. Suzuki K. 1969. Giant hepatic mitochondria: Production in mice fed with cuprizone. Science 163:81-82.
44. Veto S, Acs P, Bauer J, Lassmann H, Berente Z, Setalo G Jr., Borgulya G, Sumegi B, Komoly S, Gallyas F Jr., Illes Z. 2010. Inhibiting poly(ADP-ribose) polymerase: A potential therapy against oligodendrocyte death. Brain 133:822-834.
45. Villunger A, Michalak EM, Coultas L, Mullauer F, Bock G, Ausserlechner MJ, Adams JM, Strasser A. 2003. p53- and drug-induced apoptotic responses mediated by BH3-only proteins puma and noxa. Science 302:1036-1038.
46. Wang P, Yu J, Zhang L. 2007. The nuclear function of p53 is required for PUMA-mediated apoptosis induced by DNA damage. Proc Natl Acad Sci USA 104:4054-4059.
47. Watkins TA, Emery B, Mulinyawe S, Barres BA. 2008. Distinct stages of myelination regulated by gamma-secretase and astrocytes in a rapidly myelinating CNS coculture system. Neuron 60:555-569.
48. Willis SN, Fletcher JI, Kaufmann T, van Delft MF, Chen L, Czabotar PE, Ierino H, Lee EF, Fairlie WD, Bouillet P, Strasser A, Kluck RM, Adams JM, Huang DC. 2007. Apoptosis initiated when BH3 ligands engage multiple Bcl-2 homologs, not Bax or Bak. Science 315:856-859.
49. Wosik K, Antel J, Kuhlmann T, Bruck W, Massie B, Nalbantoglu J. 2003. Oligodendrocyte injury in multiple sclerosis: A role for p53. J Neurochem 85:635-644.
50. Wosik K, Ruffini F, Almazan G, Olivier A, Nalbantoglu J, Antel JP. 2004. Resistance of human adult oligodendrocytes to AMPA/kainate receptor-mediated glutamate injury. Brain 127:2636-2648.
51. Wyttenbach A, Tolkovsky AM. 2006. The BH3-only protein Puma is both necessary and sufficient for neuronal apoptosis induced by DNA damage in sympathetic neurons. J Neurochem 96:1213-1226.
52. Yong V, Antel J. 1992. Culture of glial cells from human brain biopsies. In: Fedoroff S, Richardson A, editors. Protocols for neural cell culture. New Jersey: Clifton. pp 76-81.
53. Yu J, Zhang L. 2008. PUMA, a potent killer with or without p53. Oncogene 27:S71-S83.
54. Zeis T, Probst A, Steck AJ, Stadelmann C, Bruck W, Schaeren-Wiemers N. 2009. Molecular changes in white matter adjacent to an active demyelinating lesion in early multiple sclerosis. Brain Pathol 19:459-466.